Does RIOCIGUAT Cause Injection site induration? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Injection site induration have been filed in association with RIOCIGUAT (Adempas). This represents 0.0% of all adverse event reports for RIOCIGUAT.
5
Reports of Injection site induration with RIOCIGUAT
0.0%
of all RIOCIGUAT reports
0
Deaths
5
Hospitalizations
How Dangerous Is Injection site induration From RIOCIGUAT?
Of the 5 reports, 5 (100.0%) required hospitalization.
Is Injection site induration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIOCIGUAT. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does RIOCIGUAT Cause?
Death (4,500)
Dyspnoea (2,881)
Headache (2,462)
Dizziness (2,208)
Hypotension (2,192)
Nausea (2,020)
Hospitalisation (1,864)
Diarrhoea (1,790)
Fatigue (1,638)
Vomiting (1,124)
What Other Drugs Cause Injection site induration?
ETANERCEPT (1,451)
NALTREXONE (866)
ADALIMUMAB (577)
GLATIRAMER (382)
DUPILUMAB (376)
INTERFERON BETA-1A (254)
EVOLOCUMAB (229)
ENBREL (218)
LEUPROLIDE (207)
IXEKIZUMAB (177)
Which RIOCIGUAT Alternatives Have Lower Injection site induration Risk?
RIOCIGUAT vs RIPRETINIB
RIOCIGUAT vs RISANKIZUMAB
RIOCIGUAT vs RISANKIZUMAB-RZAA
RIOCIGUAT vs RISDIPLAM
RIOCIGUAT vs RISEDRONATE